Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
22
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Jarrett Jennifer | Chief Financial Officer | 5 | $0 | $0 | 2016-09-28 |
| McCourt Marion | Chief Operating Officer | 5 | $0 | $0 | 2016-09-28 |
| King Michael L | Director | 8 | $0 | $0 | 2016-09-28 |
| Hirmand Mohammad | Interim Chief Medical Officer | 26 | $0 | $119.1K | 2016-09-28 |
| Yang Tseli Lily | VP, Finance and Accounting | 9 | $0 | $0 | 2016-09-28 |
| Svoronos Dawn | Director | 22 | $0 | $910.9K | 2016-09-28 |
| VERNON W ANTHONY | Director | 39 | $610.4K | $11.22M | 2016-09-28 |
| Machado Patrick | Director | 126 | $0 | $48.15M | 2016-09-28 |
| Hung David | President and CEO | 77 | $0 | $67.52M | 2016-09-28 |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp Sec | 11 | $0 | $155.8K | 2016-09-28 |
| BLICKENSTAFF KIM D | Director | 54 | $0 | $11.41M | 2016-09-28 |
| FALBERG KATHRYN E | Director | 22 | $2.94M | $0 | 2016-09-28 |
| YARNO WENDY L | Director | 16 | $0 | $0 | 2016-09-28 |
| Bierly Rick | Chief Financial Officer | 18 | $0 | $1.79M | 2016-05-06 |
| Lobacki Joseph M | Chief Commercial Officer | 3 | $0 | $142.5K | 2016-01-04 |
| Templeman Thomas | SVP, Pharmaceutical Operations | 2 | $0 | $0 | 2015-09-30 |
| Rhodes Jennifer J | GC & Corporate Secretary | 21 | $0 | $2.03M | 2015-03-16 |
| Seely Lynn | Chief Medical Officer | 104 | $0 | $33.16M | 2015-02-17 |
| Adams Daniel | Director | 30 | $0 | $12.38M | 2014-06-27 |
| Cohen Cheryl | Chief Commercial Officer | 19 | $0 | $6.05M | 2014-02-18 |
| Kelsey Stephen Michael | SVP of New Projects | 4 | $0 | $0 | 2014-02-18 |
| Bailey Gregory | Director | 32 | $0 | $13.40M | 2012-10-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| BLICKENSTAFF KIM D | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| BLICKENSTAFF KIM D | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,284 | — | $0 | 0 | SEC↗ |
| BLICKENSTAFF KIM D | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 9,584 | — | $0 | 0 | SEC↗ |
| BLICKENSTAFF KIM D | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 12,232 | — | $0 | 0 | SEC↗ |
| BLICKENSTAFF KIM D | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 30,000 | — | $0 | 0 | SEC↗ |
| BLICKENSTAFF KIM D | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 34,500 | — | $0 | 0 | SEC↗ |
| BLICKENSTAFF KIM D | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 60,000 | — | $0 | 0 | SEC↗ |
| FALBERG KATHRYN E | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 12,232 | — | $0 | 0 | SEC↗ |
| FALBERG KATHRYN E | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 9,584 | — | $0 | 0 | SEC↗ |
| FALBERG KATHRYN E | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,284 | — | $0 | 0 | SEC↗ |
| FALBERG KATHRYN E | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| FALBERG KATHRYN E | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 30,000 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 14,474 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 1,120 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 38,530 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 2,380 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 13,560 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 3,460 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 11,740 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 16,880 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 60,000 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 24,000 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer deriv | 2016-09-28 | 2016-09-30 | 58,800 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 366,194 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 448,888 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 534,400 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 593,750 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 400,000 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 310,000 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 228,000 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 205,500 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 77,337 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer deriv | 2016-09-28 | 2016-09-30 | 266,000 | — | $0 | 0 | SEC↗ |
| Jarrett Jennifer | Chief Financial Officer | D To issuer deriv | 2016-09-28 | 2016-09-30 | 119,885 | — | $0 | 0 | SEC↗ |
| Jarrett Jennifer | Chief Financial Officer | D To issuer deriv | 2016-09-28 | 2016-09-30 | 37,463 | — | $0 | 0 | SEC↗ |
| King Michael L | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| King Michael L | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 12,235 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 90,000 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,284 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 9,584 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 222,800 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 264,000 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 33,336 | — | $0 | 0 | SEC↗ |
| McCourt Marion | Chief Operating Officer | D To issuer deriv | 2016-09-28 | 2016-09-30 | 80,905 | — | $0 | 0 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | D To issuer deriv | 2016-09-28 | 2016-09-30 | 40,860 | — | $0 | 0 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | D To issuer deriv | 2016-09-28 | 2016-09-30 | 14,474 | — | $0 | 0 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | D To issuer deriv | 2016-09-28 | 2016-09-30 | 38,530 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 12,232 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 30,000 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 9,584 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,284 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 11,046 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 12,232 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 30,000 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 60,000 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 9,584 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,284 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 60,000 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 60,000 | — | $0 | 0 | SEC↗ |
| Yang Tseli Lily | VP, Finance and Accounting | D To issuer deriv | 2016-09-28 | 2016-09-30 | 25,690 | — | $0 | 0 | SEC↗ |
| Yang Tseli Lily | VP, Finance and Accounting | D To issuer deriv | 2016-09-28 | 2016-09-30 | 33,388 | — | $0 | 0 | SEC↗ |
| Yang Tseli Lily | VP, Finance and Accounting | D To issuer deriv | 2016-09-28 | 2016-09-30 | 7,750 | — | $0 | 0 | SEC↗ |
| YARNO WENDY L | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 12,232 | — | $0 | 0 | SEC↗ |
| YARNO WENDY L | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,284 | — | $0 | 0 | SEC↗ |
| YARNO WENDY L | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 30,000 | — | $0 | 0 | SEC↗ |
| YARNO WENDY L | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 9,584 | — | $0 | 0 | SEC↗ |
| YARNO WENDY L | Director | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| BLICKENSTAFF KIM D | Director | U Tender | 2016-09-28 | 2016-09-30 | 43,242 | — | $0 | 0 | SEC↗ |
| FALBERG KATHRYN E | Director | U Tender | 2016-09-28 | 2016-09-30 | 50,000 | — | $0 | 0 | SEC↗ |
| FALBERG KATHRYN E | Director | U Tender | 2016-09-28 | 2016-09-30 | 32,742 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | D To issuer | 2016-09-28 | 2016-09-30 | 18,684 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | U Tender | 2016-09-28 | 2016-09-30 | 39,068 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | U Tender | 2016-09-28 | 2016-09-30 | 1,470,087 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | D To issuer | 2016-09-28 | 2016-09-30 | 94,290 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | U Tender | 2016-09-28 | 2016-09-30 | 145,120 | — | $0 | 0 | SEC↗ |
| Jarrett Jennifer | Chief Financial Officer | D To issuer | 2016-09-28 | 2016-09-30 | 29,971 | — | $0 | 0 | SEC↗ |
| King Michael L | Director | D To issuer | 2016-09-28 | 2016-09-30 | 6,118 | — | $0 | 0 | SEC↗ |
| King Michael L | Director | U Tender | 2016-09-28 | 2016-09-30 | 2,972 | — | $0 | 0 | SEC↗ |
| Machado Patrick | Director | U Tender | 2016-09-28 | 2016-09-30 | 70,792 | — | $0 | 0 | SEC↗ |
| McCourt Marion | Chief Operating Officer | D To issuer | 2016-09-28 | 2016-09-30 | 40,453 | — | $0 | 0 | SEC↗ |
| McCourt Marion | Chief Operating Officer | U Tender | 2016-09-28 | 2016-09-30 | 541 | — | $0 | 0 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | D To issuer | 2016-09-28 | 2016-09-30 | 22,920 | — | $0 | 0 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | U Tender | 2016-09-28 | 2016-09-30 | 5,597 | — | $0 | 0 | SEC↗ |
| Svoronos Dawn | Director | U Tender | 2016-09-28 | 2016-09-30 | 21,206 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | U Tender | 2016-09-28 | 2016-09-30 | 17,742 | — | $0 | 0 | SEC↗ |
| VERNON W ANTHONY | Director | U Tender | 2016-09-28 | 2016-09-30 | 15,000 | — | $0 | 0 | SEC↗ |
| Yang Tseli Lily | VP, Finance and Accounting | D To issuer | 2016-09-28 | 2016-09-30 | 22,894 | — | $0 | 0 | SEC↗ |
| Yang Tseli Lily | VP, Finance and Accounting | U Tender | 2016-09-28 | 2016-09-30 | 541 | — | $0 | 0 | SEC↗ |
| YARNO WENDY L | Director | U Tender | 2016-09-28 | 2016-09-30 | 32,742 | — | $0 | 0 | SEC↗ |
| BLICKENSTAFF KIM D | Director | M Exercise deriv | 2016-09-21 | 2016-09-26 | 25,500 | — | $0 | 34,500 | SEC↗ |
| BLICKENSTAFF KIM D | Director | M Exercise | 2016-09-21 | 2016-09-26 | 25,500 | $2.21 | $56.4K | 43,242 | SEC↗ |
| Hung David | President and CEO | M Exercise deriv | 2016-09-15 | 2016-09-19 | 21,308 | — | $0 | 366,194 | SEC↗ |
| Hung David | President and CEO | M Exercise deriv | 2016-09-15 | 2016-09-19 | 9,446 | — | $0 | 448,888 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | M Exercise deriv | 2016-09-15 | 2016-09-19 | 11,940 | — | $0 | 0 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | M Exercise deriv | 2016-09-15 | 2016-09-19 | 5,620 | — | $0 | 0 | SEC↗ |
| Hung David | President and CEO | M Exercise | 2016-09-15 | 2016-09-19 | 9,446 | $5.29 | $50.0K | 1,543,069 | SEC↗ |
| Hung David | President and CEO | M Exercise | 2016-09-15 | 2016-09-19 | 21,308 | $4.69 | $99.9K | 1,564,377 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | M Exercise | 2016-09-15 | 2016-09-19 | 5,620 | $4.00 | $22.5K | 45,583 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | M Exercise | 2016-09-15 | 2016-09-19 | 11,940 | $4.69 | $56.0K | 57,523 | SEC↗ |
| BLICKENSTAFF KIM D | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| FALBERG KATHRYN E | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| King Michael L | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| Machado Clarence Patrick | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| Svoronos Dawn | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| VERNON W ANTHONY | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| YARNO WENDY L | Director | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| BLICKENSTAFF KIM D | Director | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 17,742 | SEC↗ |
| FALBERG KATHRYN E | Director | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 32,742 | SEC↗ |
| King Michael L | Director | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 9,090 | SEC↗ |
| Machado Clarence Patrick | Director | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 70,792 | SEC↗ |
| Svoronos Dawn | Director | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 21,206 | SEC↗ |
| VERNON W ANTHONY | Director | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 17,742 | SEC↗ |
| YARNO WENDY L | Director | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 32,742 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | S Sale | 2016-06-06 | 2016-06-06 | 2,578 | $60.42 | $155.8K | 28,517 | SEC↗ |
| Bierly Rick | CFO (former) | S Sale | 2016-05-06 | 2016-05-09 | 400 | $60.66 | $24.3K | 28,744 | SEC↗ |
| Bierly Rick | CFO (former) | S Sale | 2016-05-06 | 2016-05-09 | 5,915 | $60.08 | $355.4K | 29,144 | SEC↗ |
| Bierly Rick | CFO (former) | S Sale | 2016-05-05 | 2016-05-09 | 4,025 | $59.20 | $238.3K | 35,059 | SEC↗ |
| Jarrett Jennifer | Chief Financial Officer | A Award deriv | 2016-04-08 | 2016-04-08 | 119,885 | — | $0 | 119,885 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | A Award deriv | 2016-04-08 | 2016-04-08 | 1,120 | — | $0 | 1,120 | SEC↗ |
| Jarrett Jennifer | Chief Financial Officer | A Award | 2016-04-07 | 2016-04-08 | 29,971 | — | $0 | 29,971 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | A Award | 2016-04-06 | 2016-04-08 | 560 | — | $0 | 40,239 | SEC↗ |
| Svoronos Dawn | Director | S Sale | 2016-03-14 | 2016-03-16 | 6,000 | $38.90 | $233.4K | 18,234 | SEC↗ |
| Bierly Rick | Chief Financial Officer | S Sale | 2016-03-04 | 2016-03-07 | 1,875 | $40.00 | $75.0K | 39,084 | SEC↗ |
| Bierly Rick | Chief Financial Officer | S Sale | 2016-03-04 | 2016-03-07 | 1,123 | $40.00 | $44.9K | 40,959 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | S Sale | 2016-03-04 | 2016-03-07 | 1,525 | $41.10 | $62.7K | 39,342 | SEC↗ |
| Hung David | President and CEO | S Sale | 2016-03-04 | 2016-03-07 | 5,085 | $41.10 | $209.0K | 1,549,189 | SEC↗ |
| Bierly Rick | Chief Financial Officer | A Award deriv | 2016-02-29 | 2016-03-02 | 51,380 | — | $0 | 51,380 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | A Award deriv | 2016-02-29 | 2016-03-02 | 38,530 | — | $0 | 38,530 | SEC↗ |
| Hung David | President and CEO | A Award deriv | 2016-02-29 | 2016-03-02 | 205,500 | — | $0 | 205,500 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | A Award deriv | 2016-02-29 | 2016-03-02 | 38,530 | — | $0 | 38,530 | SEC↗ |
| Yang Tseli Lily | VP, Finance and Accounting | A Award deriv | 2016-02-29 | 2016-03-02 | 25,690 | — | $0 | 25,690 | SEC↗ |
| Bierly Rick | Chief Financial Officer | A Award | 2016-02-18 | 2016-03-02 | 12,400 | — | $0 | 42,082 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | A Award | 2016-02-18 | 2016-03-02 | 9,300 | — | $0 | 40,413 | SEC↗ |
| Hung David | President and CEO | A Award | 2016-02-18 | 2016-03-02 | 49,620 | — | $0 | 1,554,274 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | A Award | 2016-02-18 | 2016-03-02 | 9,300 | — | $0 | 38,250 | SEC↗ |
| Yang Tseli Lily | VP, Finance and Accounting | A Award | 2016-02-18 | 2016-03-02 | 6,200 | — | $0 | 22,894 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | A Award | 2016-02-18 | 2016-03-22 | 9,300 | — | $0 | 29,930 | SEC↗ |
| McCourt Marion | Chief Operating Officer | A Award deriv | 2016-02-16 | 2016-02-17 | 80,905 | — | $0 | 80,905 | SEC↗ |
| Hung David | President and CEO | S Sale | 2016-02-04 | 2016-02-05 | 6,350 | $31.18 | $198.0K | 1,504,654 | SEC↗ |
| McCourt Marion | Chief Operating Officer | A Award | 2016-02-03 | 2016-02-04 | 40,453 | — | $0 | 40,453 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise deriv | 2016-01-19 | 2016-01-21 | 75,000 | — | $0 | 33,336 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2016-01-19 | 2016-01-21 | 37,021 | $36.62 | $1.36M | 104,135 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2016-01-19 | 2016-01-21 | 6,950 | $39.19 | $272.4K | 66,156 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2016-01-19 | 2016-01-21 | 23,087 | $37.50 | $865.8K | 81,048 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2016-01-19 | 2016-01-21 | 7,942 | $38.62 | $306.7K | 73,106 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise | 2016-01-19 | 2016-01-21 | 75,000 | $3.37 | $252.8K | 141,156 | SEC↗ |
| Lobacki Joseph M | Chief Commercial Officer | S Sale | 2016-01-04 | 2016-01-05 | 3,065 | $46.50 | $142.5K | 19,365 | SEC↗ |
| VERNON W ANTHONY | Director | G Gift | 2015-12-14 | 2015-12-16 | 13,704 | — | $0 | 15,000 | SEC↗ |
| VERNON W ANTHONY | Director | P Buy | 2015-12-14 | 2015-12-16 | 15,000 | $40.69 | $610.4K | 28,704 | SEC↗ |
| King Michael L | Director | A Award deriv | 2015-12-04 | 2015-12-08 | 12,235 | — | $0 | 12,235 | SEC↗ |
| King Michael L | Director | A Award | 2015-12-04 | 2015-12-08 | 6,118 | — | $0 | 6,118 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | S Sale | 2015-12-03 | 2015-12-04 | 1,075 | $43.40 | $46.7K | 31,113 | SEC↗ |
| Hung David | President and CEO | S Sale | 2015-12-03 | 2015-12-04 | 10,950 | $43.10 | $471.9K | 1,511,004 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | S Sale | 2015-11-09 | 2015-11-12 | 232 | $41.91 | $9.7K | 32,188 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | A Award deriv | 2015-09-30 | 2015-10-01 | 2,380 | — | $0 | 2,380 | SEC↗ |
| Templeman Thomas | SVP, Pharmaceutical Operatio | A Award deriv | 2015-09-30 | 2015-10-01 | 45,440 | — | $0 | 45,440 | SEC↗ |
| Yang Tseli Lily | VP, Finance and Accounting | A Award deriv | 2015-09-30 | 2015-10-01 | 33,388 | — | $0 | 33,388 | SEC↗ |
| Hirmand Mohammad | Interim Chief Medical Office | A Award | 2015-09-29 | 2015-10-01 | 1,190 | — | $0 | 32,420 | SEC↗ |
| Templeman Thomas | SVP, Pharmaceutical Operatio | A Award | 2015-09-29 | 2015-10-01 | 22,720 | — | $0 | 22,720 | SEC↗ |
| Yang Tseli Lily | VP, Finance and Accounting | A Award | 2015-09-29 | 2015-10-01 | 16,694 | — | $0 | 16,694 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise deriv | 2015-09-25 | 2015-09-28 | 71,980 | — | $0 | 0 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-09-25 | 2015-09-28 | 22,236 | $41.63 | $925.7K | 104,300 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-09-25 | 2015-09-28 | 20,464 | $42.68 | $873.4K | 83,836 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise | 2015-09-25 | 2015-09-28 | 71,980 | $4.69 | $337.6K | 138,136 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-09-25 | 2015-09-28 | 17,680 | $43.92 | $776.5K | 66,156 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-09-25 | 2015-09-28 | 11,600 | $40.82 | $473.5K | 125,536 | SEC↗ |
| Svoronos Dawn | Director | S Sale | 2015-09-08 | 2015-09-08 | 3,100 | $89.15 | $276.4K | 12,117 | SEC↗ |
| BLICKENSTAFF KIM D | Director | A Award deriv | 2015-06-16 | 2015-06-18 | 3,142 | — | $0 | 3,142 | SEC↗ |
| FALBERG KATHRYN E | Director | A Award deriv | 2015-06-16 | 2015-06-18 | 3,142 | — | $0 | 3,142 | SEC↗ |
| Machado Clarence Patrick | Director | A Award deriv | 2015-06-16 | 2015-06-18 | 3,142 | — | $0 | 3,142 | SEC↗ |
| Svoronos Dawn | Director | A Award deriv | 2015-06-16 | 2015-06-18 | 3,142 | — | $0 | 3,142 | SEC↗ |
| VERNON W ANTHONY | Director | A Award deriv | 2015-06-16 | 2015-06-18 | 3,142 | — | $0 | 3,142 | SEC↗ |
| YARNO WENDY L | Director | A Award deriv | 2015-06-16 | 2015-06-18 | 3,142 | — | $0 | 3,142 | SEC↗ |
| BLICKENSTAFF KIM D | Director | A Award | 2015-06-16 | 2015-06-18 | 1,578 | — | $0 | 7,385 | SEC↗ |
| FALBERG KATHRYN E | Director | A Award | 2015-06-16 | 2015-06-18 | 1,578 | — | $0 | 14,885 | SEC↗ |
| Machado Clarence Patrick | Director | A Award | 2015-06-16 | 2015-06-18 | 1,578 | — | $0 | 33,078 | SEC↗ |
| Svoronos Dawn | Director | A Award | 2015-06-16 | 2015-06-18 | 1,578 | — | $0 | 15,217 | SEC↗ |
| VERNON W ANTHONY | Director | A Award | 2015-06-16 | 2015-06-18 | 1,578 | — | $0 | 14,217 | SEC↗ |
| YARNO WENDY L | Director | A Award | 2015-06-16 | 2015-06-18 | 1,578 | — | $0 | 14,885 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise deriv | 2015-06-04 | 2015-06-08 | 36,000 | — | $0 | 35,990 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-06-04 | 2015-06-08 | 300 | $120.04 | $36.0K | 31,500 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise | 2015-06-04 | 2015-06-08 | 36,000 | $9.39 | $338.0K | 67,500 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-06-04 | 2015-06-08 | 16,600 | $116.12 | $1.93M | 50,900 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-06-04 | 2015-06-08 | 2,900 | $117.10 | $339.6K | 48,000 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-06-04 | 2015-06-08 | 6,600 | $118.38 | $781.3K | 41,400 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-06-04 | 2015-06-08 | 9,600 | $119.06 | $1.14M | 31,800 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | A Award deriv | 2015-06-01 | 2015-06-02 | 20,430 | — | $0 | 20,430 | SEC↗ |
| Powell Andrew Kenneth William | SVP, General Counsel & Crp S | A Award | 2015-05-27 | 2015-05-29 | 10,215 | — | $0 | 10,315 | SEC↗ |
| Bierly Rick | Chief Financial Officer | S Sale | 2015-05-20 | 2015-05-20 | 1,000 | $130.00 | $130.0K | 14,841 | SEC↗ |
| Bierly Rick | Chief Financial Officer | S Sale | 2015-05-08 | 2015-05-12 | 385 | $125.00 | $48.1K | 15,841 | SEC↗ |
| Bierly Rick | Chief Financial Officer | S Sale | 2015-05-05 | 2015-05-06 | 1,615 | $125.00 | $201.9K | 16,226 | SEC↗ |
| Bierly Rick | Chief Financial Officer | S Sale | 2015-05-04 | 2015-05-06 | 2,170 | $124.70 | $270.6K | 17,841 | SEC↗ |
| Bierly Rick | Chief Financial Officer | M Exercise deriv | 2015-04-15 | 2015-04-16 | 3,000 | — | $0 | 28,023 | SEC↗ |
| Bierly Rick | Chief Financial Officer | M Exercise | 2015-04-15 | 2015-04-16 | 3,000 | $58.10 | $174.3K | 23,011 | SEC↗ |
| Bierly Rick | Chief Financial Officer | S Sale | 2015-04-15 | 2015-04-16 | 3,000 | $132.20 | $396.6K | 20,011 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | S Sale | 2015-03-16 | 2015-03-17 | 1,390 | $130.92 | $182.0K | 11,090 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | M Exercise deriv | 2015-03-02 | 2015-03-02 | 2,000 | — | $0 | 38,000 | SEC↗ |
| Hung David | President and CEO | S Sale | 2015-03-02 | 2015-03-02 | 32,191 | $121.49 | $3.91M | 760,977 | SEC↗ |
| Hung David | President and CEO | S Sale | 2015-03-02 | 2015-03-02 | 68,700 | $120.52 | $8.28M | 793,168 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | S Sale | 2015-03-02 | 2015-03-02 | 2,000 | $122.00 | $244.0K | 12,480 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | M Exercise | 2015-03-02 | 2015-03-02 | 2,000 | $47.48 | $95.0K | 14,480 | SEC↗ |
| Svoronos Dawn | Director | S Sale | 2015-03-02 | 2015-03-04 | 3,350 | $119.75 | $401.2K | 13,639 | SEC↗ |
| FALBERG KATHRYN E | Director | P Buy | 2015-02-27 | 2015-03-02 | 19,400 | $117.76 | $2.28M | 22,800 | SEC↗ |
| FALBERG KATHRYN E | Director | P Buy | 2015-02-27 | 2015-03-02 | 3,400 | $116.51 | $396.1K | 3,400 | SEC↗ |
| FALBERG KATHRYN E | Director | P Buy | 2015-02-27 | 2015-03-02 | 800 | $119.11 | $95.3K | 25,000 | SEC↗ |
| FALBERG KATHRYN E | Director | P Buy | 2015-02-27 | 2015-03-02 | 1,400 | $118.37 | $165.7K | 24,200 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | M Exercise deriv | 2015-02-26 | 2015-02-27 | 2,000 | — | $0 | 40,000 | SEC↗ |
| Hung David | President and CEO | S Sale | 2015-02-26 | 2015-02-27 | 19,109 | $120.12 | $2.30M | 861,868 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | S Sale | 2015-02-26 | 2015-02-27 | 1,089 | $118.00 | $128.5K | 13,391 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | M Exercise | 2015-02-26 | 2015-02-27 | 2,000 | $47.48 | $95.0K | 14,480 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | S Sale | 2015-02-26 | 2015-02-27 | 2,000 | $120.00 | $240.0K | 11,391 | SEC↗ |
| Bierly Rick | Chief Financial Officer | A Award deriv | 2015-02-17 | 2015-02-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Hung David | President and CEO | A Award deriv | 2015-02-17 | 2015-02-18 | 114,000 | — | $0 | 114,000 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | A Award deriv | 2015-02-17 | 2015-02-18 | 19,000 | — | $0 | 19,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | A Award deriv | 2015-02-17 | 2015-02-18 | 31,000 | — | $0 | 31,000 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise deriv | 2015-02-10 | 2015-02-12 | 36,000 | — | $0 | 71,990 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-02-10 | 2015-02-12 | 700 | $101.27 | $70.9K | 66,800 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise | 2015-02-10 | 2015-02-12 | 36,000 | $9.39 | $338.0K | 67,500 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-02-10 | 2015-02-12 | 3,400 | $102.37 | $348.1K | 63,400 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-02-10 | 2015-02-12 | 20,700 | $104.35 | $2.16M | 31,500 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-02-10 | 2015-02-12 | 11,200 | $103.66 | $1.16M | 52,200 | SEC↗ |
| Bierly Rick | Chief Financial Officer | A Award | 2015-02-09 | 2015-02-11 | 4,500 | — | $0 | 20,011 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | A Award | 2015-02-09 | 2015-02-11 | 3,500 | — | $0 | 12,480 | SEC↗ |
| Hung David | President and CEO | A Award | 2015-02-09 | 2015-02-11 | 21,000 | — | $0 | 882,868 | SEC↗ |
| Seely Lynn | Chief Medical Officer | A Award | 2015-02-09 | 2015-02-11 | 5,500 | — | $0 | 96,694 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | S Sale | 2015-02-04 | 2015-02-06 | 610 | $100.85 | $61.5K | 8,980 | SEC↗ |
| Hung David | President and CEO | S Sale | 2015-02-04 | 2015-02-06 | 3,190 | $100.48 | $320.5K | 861,868 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise deriv | 2015-01-27 | 2015-01-29 | 28,706 | — | $0 | 107,990 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise deriv | 2015-01-27 | 2015-01-29 | 7,294 | — | $0 | 0 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise | 2015-01-27 | 2015-01-29 | 28,706 | $9.39 | $269.5K | 67,500 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-01-27 | 2015-01-29 | 17,200 | $104.93 | $1.80M | 50,300 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2015-01-27 | 2015-01-29 | 18,800 | $105.67 | $1.99M | 31,500 | SEC↗ |
| Machado Clarence Patrick | Director | M Exercise | 2015-01-27 | 2015-01-29 | 7,294 | $10.59 | $77.2K | 38,794 | SEC↗ |
| Hung David | President and CEO | S Sale | 2015-01-20 | 2015-01-22 | 14,900 | $109.17 | $1.63M | 865,058 | SEC↗ |
| Hung David | President and CEO | S Sale | 2015-01-20 | 2015-01-22 | 64,234 | $108.09 | $6.94M | 879,958 | SEC↗ |
| Hung David | President and CEO | S Sale | 2015-01-20 | 2015-01-22 | 20,866 | $107.57 | $2.24M | 944,192 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-12-19 | 2014-12-22 | 10,654 | — | $0 | 0 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-12-19 | 2014-12-22 | 20,686 | — | $0 | 89,314 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-12-19 | 2014-12-22 | 10,654 | $9.39 | $100.0K | 91,194 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-12-19 | 2014-12-22 | 20,686 | $10.59 | $219.1K | 80,540 | SEC↗ |
| Lobacki Joseph M | Chief Commercial Officer | A Award deriv | 2014-12-15 | 2014-12-15 | 22,420 | — | $0 | 22,420 | SEC↗ |
| Lobacki Joseph M | Chief Commercial Officer | A Award | 2014-12-12 | 2014-12-15 | 11,215 | — | $0 | 11,215 | SEC↗ |
| Hung David | President and CEO | S Sale | 2014-12-03 | 2014-12-04 | 5,420 | $113.00 | $612.5K | 965,058 | SEC↗ |
| Machado Clarence Patrick | Director | S Sale | 2014-12-03 | 2014-12-04 | 1,580 | $113.00 | $178.5K | 31,500 | SEC↗ |
| Rhodes Jennifer J | GC & Corporate Secretary | S Sale | 2014-12-03 | 2014-12-04 | 910 | $113.00 | $102.8K | 9,590 | SEC↗ |
| Hung David | President and CEO | G Gift | 2014-11-03 | 2014-12-04 | 4,716 | — | $0 | 970,478 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-10-22 | 2014-10-23 | 5,000 | — | $0 | 110,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-10-22 | 2014-10-23 | 5,000 | $10.59 | $53.0K | 64,854 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-10-22 | 2014-10-23 | 5,000 | $99.03 | $495.1K | 59,854 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-10-16 | 2014-10-17 | 5,000 | — | $0 | 115,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-10-16 | 2014-10-17 | 5,000 | $93.97 | $469.9K | 59,854 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-10-16 | 2014-10-17 | 5,000 | $10.59 | $53.0K | 64,854 | SEC↗ |
| Hung David | President and CEO | G Gift | 2014-10-16 | 2014-12-04 | 10 | — | $0 | 975,194 | SEC↗ |
| Svoronos Dawn | Director | A Award deriv | 2014-10-15 | 2014-10-16 | 5,523 | — | $0 | 5,523 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-10-15 | 2014-10-17 | 4,346 | — | $0 | 10,654 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-10-15 | 2014-10-17 | 5,000 | — | $0 | 120,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-10-15 | 2014-10-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Svoronos Dawn | Director | A Award | 2014-10-15 | 2014-10-16 | 3,682 | — | $0 | 16,989 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-10-15 | 2014-10-17 | 5,000 | $10.59 | $53.0K | 64,854 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-10-15 | 2014-10-17 | 4,346 | $9.39 | $40.8K | 69,200 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-10-15 | 2014-10-17 | 15,000 | $6.74 | $101.1K | 84,200 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-10-15 | 2014-10-17 | 12,300 | $88.94 | $1.09M | 68,900 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-10-15 | 2014-10-17 | 3,000 | $87.61 | $262.8K | 81,200 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-10-15 | 2014-10-17 | 8,946 | $89.82 | $803.5K | 59,954 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-10-15 | 2014-10-17 | 100 | $90.41 | $9.0K | 59,854 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-09-18 | 2014-09-18 | 25,000 | — | $0 | 125,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-09-18 | 2014-09-18 | 25,000 | $10.59 | $264.8K | 84,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-09-18 | 2014-09-18 | 7,200 | $100.44 | $723.2K | 59,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-09-18 | 2014-09-18 | 17,800 | $99.55 | $1.77M | 66,222 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-09-17 | 2014-09-18 | 15,000 | — | $0 | 30,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-09-17 | 2014-09-18 | 10,000 | — | $0 | 150,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-09-17 | 2014-09-18 | 5,000 | — | $0 | 15,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-09-17 | 2014-09-18 | 10,000 | $10.59 | $105.9K | 69,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-09-17 | 2014-09-18 | 3,400 | $98.16 | $333.7K | 59,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-09-17 | 2014-09-18 | 13,300 | $97.66 | $1.30M | 62,422 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-09-17 | 2014-09-18 | 13,300 | $96.85 | $1.29M | 75,722 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-09-17 | 2014-09-18 | 15,000 | $6.74 | $101.1K | 89,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-09-17 | 2014-09-18 | 5,000 | $9.39 | $47.0K | 74,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-09-09 | 2014-09-11 | 20,000 | — | $0 | 160,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-09-09 | 2014-09-11 | 5,187 | $95.06 | $493.1K | 59,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-09-09 | 2014-09-11 | 14,813 | $94.44 | $1.40M | 64,209 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-09-09 | 2014-09-11 | 20,000 | $10.59 | $211.8K | 79,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-08-27 | 2014-08-28 | 14,300 | — | $0 | 180,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-08-27 | 2014-08-28 | 11,700 | $89.43 | $1.05M | 61,622 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-08-27 | 2014-08-28 | 14,300 | $10.59 | $151.4K | 73,322 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-08-27 | 2014-08-28 | 2,600 | $90.42 | $235.1K | 59,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-08-26 | 2014-08-28 | 5,700 | — | $0 | 194,300 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-08-26 | 2014-08-28 | 5,700 | $88.95 | $507.0K | 59,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-08-26 | 2014-08-28 | 5,700 | $10.59 | $60.4K | 64,722 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-08-13 | 2014-08-14 | 12,500 | — | $0 | 20,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-08-13 | 2014-08-14 | 7,500 | — | $0 | 45,000 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-08-13 | 2014-08-14 | 3,300 | $84.63 | $279.3K | 59,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-08-13 | 2014-08-14 | 5,700 | $84.01 | $478.9K | 62,322 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-08-13 | 2014-08-14 | 12,500 | $9.39 | $117.4K | 71,522 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise | 2014-08-13 | 2014-08-14 | 7,500 | $6.74 | $50.5K | 79,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | S Sale | 2014-08-13 | 2014-08-14 | 11,000 | $83.12 | $914.3K | 68,022 | SEC↗ |
| Seely Lynn | Chief Medical Officer | M Exercise deriv | 2014-08-12 | 2014-08-12 | 12,500 | — | $0 | 32,500 | SEC↗ |